Prestige Consumer Healthcare Inc. (PBH) key performance indicators and operating metrics (10 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| International OTC Healthcare Segment Revenue | 47.1M | FY2026-Q4 |
| North American OTC Healthcare Segment Revenue | 234.5M | FY2026-Q4 |
| Adjusted Net Income | 58.5M | FY2026-Q4 |
| Adjusted Diluted Earnings Per Share | 1.23 USD_per_share | FY2026-Q4 |
| Non-GAAP Adjusted Net Income | 54.9M | FY2026-Q3 |
| Covenant-Defined Leverage Ratio | 2.60 ratio | FY2026-Q3 |
| Adjusted Diluted Earnings per Share (Non-GAAP) | 1.14 USD_per_share | FY2026-Q3 |
| Net Debt Position | 900M | FY2026-Q2 |
| Non-GAAP Free Cash Flow | 78.2M | FY2026-Q1 |
| Net Cash Provided by Operating Activities | 48.13M | FY2026-Q1 |
Back to PBH overview · PBH earnings · PBH holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.